Qritive
Singapore
- Singapore, Singapore
- 11/01/2023
- Unknown
- $7,500,000
Qritive makes cancer diagnosis fast, cheap, and accurate.
During our lifetime, 1 in 3 of us will get cancer. But cancer diagnosis is slow and expensive because doctors are not equipped with modern automated tools. Qritive provides an AI-powered solution to help doctors analyse both microscopy images and text from patient data. As a result, hospitals will be more efficient in making cancer diagnoses, allowing them to save costs.
- Industry Software Development
- Website https://qritive.com/
- LinkedIn https://www.linkedin.com/company/qritive/
Related People
Aneesh Sathe, Ph.D.Co Founder
United States -
ND
At Qritive, we make cancer diagnosis fast, accurate, and affordable.
Qritive provides an AI-powered solution to help doctors analyse microscopy images for histopathology. As a result, hospitals and labs will be more efficient in making cancer diagnoses, allowing them to save costs.
Syntracts | $5,300,000 | (Oct 24, 2025)
GradBridge | $20,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
CipherOwl | $15,000,000 | (Oct 24, 2025)
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
Vermeer | $10,000,000 | (Oct 24, 2025)
GammaTime | $14,000,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Apriority Financial, Inc. | $2,300,000 | (Oct 24, 2025)
OneAM | $4,700,000 | (Oct 24, 2025)
🌱 Rightcharge | $2,131,920 | (Oct 24, 2025)
Tensormesh | $4,500,000 | (Oct 24, 2025)